Comparison of the Impact of Diet vs Thiazide in BMD in Children With Idiopathic Hypercalciuria
Status:
Unknown status
Trial end date:
2020-06-30
Target enrollment:
Participant gender:
Summary
The investigator's objective is to compare and evaluate the impact of nutritional treatment
vs. pharmacological treatment (hydrochlorothiazide) in bone mineral density in children with
idiopathic hypercalciuria.
A randomized, open-label, one-year follow-up study will be conducted in children aged 5 to 21
years with a confirmed diagnosis of idiopathic hypercalciuria or lithiasis, excluding those
patients with secondary hypercalciuria (primary hyperoxaluria, treatment with vitamin D,
Bartter syndrome, primary hyperparathyroidism), previous kidney transplantation. The impact
of diet (hyposodic, calcium intake according to DIR for age, normal protein intake and high
water intake) will be evaluated vs. the pharmacological treatment (hydrochlorothiazide) on
bone mineral density.